Last reviewed · How we verify
Inflammatory dermatosis
Approved treatments
- Temovate · Fougera Pharms
- Cortifoam · Pfizer
- Cortone
- Cortef · Generic (originally Merck/Upjohn)
- Lidex
- Cortisol · University of Zurich
- pramocaine
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Inflammatory dermatosis patent landscape — cliff calendar, originator estates, attackable patents
- Inflammatory dermatosis treatment landscape brief
- Inflammatory dermatosis treatment updates RSS
Frequently asked questions about Inflammatory dermatosis
What drugs treat Inflammatory dermatosis?
Tracked treatments include Temovate, Cortifoam, Cortone, Cortef, Lidex, Cortisol, pramocaine.
What is the treatment for Inflammatory dermatosis?
Standard treatment for Inflammatory dermatosis includes Temovate, Cortifoam, Cortone, Cortef, Lidex. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Inflammatory dermatosis patent cliff · Inflammatory dermatosis CI report
- Treatment: Temovate · Fougera Pharms
- Treatment: Cortifoam · Pfizer
- Treatment: Cortone
- Treatment: Cortef · Generic (originally Merck/Upjohn)
- Treatment: Lidex
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing